Utilizing mouse optic nerve crush to examine CNS remyelination.


Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
17 09 2021
Historique:
entrez: 17 11 2021
pubmed: 18 11 2021
medline: 18 11 2021
Statut: epublish

Résumé

In developing pro-myelination treatment, an important hurdle is the lack of reliable animal models for assessing de novo myelination in disease settings. We recently showed that regenerated axons in injured optic nerves fail to be myelinated, providing an animal model for this purpose. Here, we describe procedures to promote axonal regeneration, administer optic nerve crush, and assess oligodendrocyte differentiation and maturation into myelination-competent oligodendrocytes. This protocol allows for testing the efficacy of remyelination treatments in an

Identifiants

pubmed: 34786561
doi: 10.1016/j.xpro.2021.100796
pii: S2666-1667(21)00502-5
pmc: PMC8579818
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100796

Subventions

Organisme : NEI NIH HHS
ID : R01 EY021526
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD105351
Pays : United States
Organisme : NEI NIH HHS
ID : F32 EY032779
Pays : United States
Organisme : NINDS NIH HHS
ID : F31 NS098643
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026939
Pays : United States

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

Z.H. is a co-founder and consultant of Myro Therapeutics. Z. H. and J.W. are co-inventors of a patent related to the pro-myelination methods.

Références

Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Genesis. 2003 Jan;35(1):63-72
pubmed: 12481300
J Vis Exp. 2011 Apr 25;(50):
pubmed: 21540827
Neuron. 2010 Nov 18;68(4):668-81
pubmed: 21092857
Cell. 2016 Jan 14;164(1-2):219-232
pubmed: 26771493
PLoS One. 2011;6(12):e29423
pubmed: 22216277
Neuron. 2020 Dec 9;108(5):876-886.e4
pubmed: 33108748
Cell. 2014 Nov 6;159(4):896-910
pubmed: 25417164
PLoS Biol. 2005 May;3(5):e159
pubmed: 15836427

Auteurs

Tracey A C S Suter (TACS)

Boston Children's Hospital | Harvard Medical School, Boston, MA 02115, USA.

Jing Wang (J)

Boston Children's Hospital | Harvard Medical School, Boston, MA 02115, USA.

Huyan Meng (H)

Boston Children's Hospital | Harvard Medical School, Boston, MA 02115, USA.

Zhigang He (Z)

Boston Children's Hospital | Harvard Medical School, Boston, MA 02115, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH